This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
DOM: Difference between revisions
>White m Text replacement - "{| |- | 17px''Main articles: Research chemicals § Toxicity and harm potential'' ''&'' ''Responsible use § Hallucinogens'' |}" to "{{further|Research chemicals#Toxicity and harm potential|Responsible use #Hallucinogens}}" |
>MDMQualone mNo edit summary |
||
| Line 105: | Line 105: | ||
*'''United States:''' DOM is a Schedule I drug. | *'''United States:''' DOM is a Schedule I drug. | ||
*'''Canada:''' DOM is a Schedule I drug. | *'''Canada:''' DOM is a Schedule I drug. | ||
*'''New Zealand:''' DOM is a Class | *'''New Zealand:''' DOM is a Class A drug. | ||
*'''Belgium:''' DOM is a Schedule I drug. | *'''Belgium:''' DOM is a Schedule I drug. | ||
*'''Latvia:''' DOM is a Schedule I controlled substance.<ref>Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem (2,5-Dimetoksifeniletānamīni) | http://likumi.lv/doc.php?id=121086</ref> | *'''Latvia:''' DOM is a Schedule I controlled substance.<ref>Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem (2,5-Dimetoksifeniletānamīni) | http://likumi.lv/doc.php?id=121086</ref> | ||
